Drug Trial Radar · NCT06643130
Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia
Last checked: Nov 19, 2026Latest source record: Sep 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
162
Planned (sponsor's estimate)
Start
Dec 2, 2024
Primary completion
Apr 2026
Study completion Apr 2026
Sponsor
- Lead sponsor
- JW PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Oct 16, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia
Conditions
- Hypertension
- Dyslipidemia
Interventions
JW0104+C2402Drug
For 8 weeks(PO (Per Oral), QD)
JW0104+C2403Drug
For 8 weeks(PO, QD)
C2402Drug
For 8 weeks(PO, QD)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in msSBP (Systolic Blood Pressure)Time frame: week 8
- Percent change from baseline in LDL-C (Low-Density Lipoprotein Cholesterol)Time frame: week 8
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Gangdong Sacred Heart Hospital
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.